Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
3.53%
0%
3.53%
6 Months
13.47%
0%
13.47%
1 Year
33.16%
0%
33.16%
2 Years
9.07%
0%
9.07%
3 Years
22.94%
0%
22.94%
4 Years
27.31%
0%
27.31%
5 Years
19.16%
0%
19.16%
Nanjing Well Pharmaceutical Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
12.39%
EBIT Growth (5y)
10.82%
EBIT to Interest (avg)
13.70
Debt to EBITDA (avg)
0.97
Net Debt to Equity (avg)
0.15
Sales to Capital Employed (avg)
0.57
Tax Ratio
15.38%
Dividend Payout Ratio
37.00%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.61%
ROE (avg)
7.02%
Valuation key factors
Factor
Value
P/E Ratio
26
Industry P/E
Price to Book Value
2.11
EV to EBIT
23.71
EV to EBITDA
13.21
EV to Capital Employed
1.96
EV to Sales
3.07
PEG Ratio
2.16
Dividend Yield
1.49%
ROCE (Latest)
8.25%
ROE (Latest)
8.07%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
356.30
316.80
12.47%
Operating Profit (PBDIT) excl Other Income
47.90
71.40
-32.91%
Interest
3.80
2.70
40.74%
Exceptional Items
0.00
-0.80
100.00%
Consolidate Net Profit
36.80
37.20
-1.08%
Operating Profit Margin (Excl OI)
134.40%
120.90%
1.35%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is 12.47% vs -8.04% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is -1.08% vs -7.92% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
1,331.90
1,288.10
3.40%
Operating Profit (PBDIT) excl Other Income
308.50
284.70
8.36%
Interest
10.80
14.30
-24.48%
Exceptional Items
3.40
12.10
-71.90%
Consolidate Net Profit
149.00
145.20
2.62%
Operating Profit Margin (Excl OI)
131.80%
130.80%
0.10%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 3.40% vs 11.74% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 2.62% vs 33.09% in Dec 2024
About Nanjing Well Pharmaceutical Co., Ltd. 
Nanjing Well Pharmaceutical Co., Ltd.
Chemicals & Petrochemicals
No Details Available.
Company Coordinates 
No Company Details Available






